CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q3 FY22 results · Oct–Dec 2021
CLNINDIA reported revenue from operations of ₹221.81 crore (up 9.8% from Q3 FY21) and net profit of ₹8.45 crore (down 36.0% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 221.81 | 202.10 | +9.8% | 194.88 | +13.8% |
| Other income | 0.18 | 3.03 | −94.1% | 0.50 | −64.0% |
| Total income | 221.99 | 205.13 | +8.2% | 195.38 | +13.6% |
| Profit before tax | 11.47 | 19.00 | −39.6% | 5.96 | +92.4% |
| Net profit for the period | 8.45 | 13.20 | −36.0% | 4.36 | +93.8% |
| EPS, basic (₹) | 3.66 | 5.72 | −36.0% | 1.89 | +93.7% |
| Net margin (%) | 3.8 | 6.5 | 2.2 |
Standalone
- Filed with BSE
- 12 Feb 2022, 15:59 IST
- Board meeting
- 10 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE